Antares Pharma Inc (NASDAQ:ATRS)

2.69
Delayed Data
As of Jun 21
 -0.13 / -4.61%
Today’s Change
1.58
Today|||52-Week Range
4.09
+35.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues26.5M45.7M52.2M54.5M
 
 
 
 
 
Cost of Goods Sold10.4M18.4M27.5M25.9M
 
 
 
 
 
Depreciation And Amortization1.2M1.6M1.9M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income14.9M25.7M22.9M26.5M
 
 
 
 
 
General Expenses48.3M46.1M47.0M42.9M
 
 
 
 
 
Research And Development18.6M19.7M21.1M13.1M
 
 
 
 
 
Total Operating Expenses59.9M66.1M76.3M71.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.4M-20.5M-24.1M-16.5M
 
 
 
 
 
Extraordinary Charge-1.7M-31.5K0.00-46.0K
 
 
 
 
Interest Expense On Debt0.000.000.001.4M
 
 
Other Expenses-90.1K-50.8K-202.1K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.1M-20.5M-24.2M-16.7M
 
 
 
 
 
Income Taxes-25.0K-175.0K-100.0K0.00
 
 
 
 
Net Income-35.2M-20.7M-24.3M-16.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS130.5M146.6M155.0M156.1M
 
 
 
 
 
Shares To Calculate EPS Diluted130.5M146.6M155.0M156.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.14-$0.16-$0.11
 
 
 
 
 
EPS Diluted-$0.27-$0.14-$0.16-$0.11